Form 4: Myriad Genetics Director Lee Nisley Newcomer Sells 6,200 Shares
SEC Form 4 Filing
Director Lee Nisley Newcomer of Myriad Genetics Inc. sold 6,200 shares of common stock at an average price of $25.30 on May 13, 2024.
Summary
- On May 13, 2024, Lee Nisley Newcomer, a director of Myriad Genetics Inc. (MYGN), sold 6,200 shares of the company's common stock.
- The shares were sold at a weighted average price of $25.30, with individual transactions ranging from $25.30 to $25.39.
- Following the transaction, Newcomer directly owns 66,650 shares of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction. The sentiment is neutral.
Industry Context
This transaction is a routine disclosure of stock trading activity by a company insider and doesn't necessarily indicate a broader trend or issue within the diagnostics industry.
Stakeholder Impact
- The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on their interpretation of the director's motives.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of transaction: Lee Nisley Newcomer sold 6,200 shares of Myriad Genetics Inc. |
| 05/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.